Published in Virology on September 01, 1976
Indiscriminate recombination in simian virus 40-infected monkey cells. Proc Natl Acad Sci U S A (1980) 2.18
Recombination between endogenous and exogenous simian virus 40 genes. I. Rescue of a simian virus 40 temperature-sensitive mutant by passage in permissive transformed monkey lines. J Virol (1977) 1.16
Recurring defective variants of simian virus 40 containing monkey DNA segments. J Virol (1981) 1.02
Circular and linear simian virus 40 DNAs differ in recombination. Mol Cell Biol (1985) 0.99
Structure of simian virus 40-phiX174 recombinant genomes isolated from single cells. J Virol (1983) 0.86
Emergence of simian virus 40 variants during serial passage of plaque isolates. J Virol (1982) 0.84
Preferential replication of a class of host-substituted defective simian virus 40 variants at low temperature. J Virol (1980) 0.78
Transcription of host-substituted simian virus 40 DNA in whole cells and extracts. J Virol (1978) 0.76
Altered restriction endonuclease cleavage pattern of simian virus 40 DNA. J Virol (1979) 0.75
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21
mdm2 expression is induced by wild type p53 activity. EMBO J (1993) 8.01
Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation. Proc Natl Acad Sci U S A (1977) 7.46
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature (1985) 6.86
Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen. Proc Natl Acad Sci U S A (1977) 6.57
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol (1988) 6.44
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell (1990) 6.37
Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci U S A (1989) 5.40
Acquisition of sequences homologous to host deoxyribonucleic acid by closed circular simian virus 40 deoxyribonucleic acid. J Virol (1972) 4.81
Characterization of the simian virus 40-specific RNA in virus-yielding and transformed cells. J Mol Biol (1968) 4.65
The induction of cellular DNA synthesis by simian virus 40 in contact-inhibited and in x-irradiated cells. Proc Natl Acad Sci U S A (1966) 4.64
Isolation and characterization of simian virus 40 ribonucleic acid. J Virol (1972) 4.09
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev (2001) 4.06
Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A (2000) 3.74
Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature (1999) 3.50
Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A (1991) 3.45
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J Virol (1987) 3.44
Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev (1995) 3.40
Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol (1983) 3.39
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol (1992) 3.37
p53 in growth control and neoplasia. Biochim Biophys Acta (1996) 3.19
Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J (1985) 3.18
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol (1985) 3.13
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene (1993) 3.08
Cell-free translation of messenger RNA of simian virus 40: synthesis of the major capsid protein. Proc Natl Acad Sci U S A (1974) 3.04
A single gene and a pseudogene for the cellular tumour antigen p53. Nature (1984) 2.98
Specific interaction between the p53 cellular tumour antigen and major heat shock proteins. Nature (1986) 2.94
Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J (1984) 2.94
Intracisternal A-particle genes: identification in the genome of Mus musculus and comparison of multiple isolates from a mouse gene library. Proc Natl Acad Sci U S A (1980) 2.94
Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem (2001) 2.93
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev (1994) 2.88
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A (1999) 2.87
Sequences associated with intracisternal A particles are reiterated in the mouse genome. Cell (1977) 2.82
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ (2009) 2.80
Intracisternal A-particle genes as movable elements in the mouse genome. Proc Natl Acad Sci U S A (1983) 2.76
Differential affinities of simian virus 40 large tumor antigen for DNA. Proc Natl Acad Sci U S A (1980) 2.75
The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A (1996) 2.74
Overproduction of p53 antigen makes established cells highly tumorigenic. Nature (1985) 2.72
Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene (1988) 2.71
On the mechanism of polyoma virus-induced synthesis of cellular DNA. Proc Natl Acad Sci U S A (1965) 2.67
Non-visualization of the cavum septi pellucidi is not synonymous with agenesis of the corpus callosum. Ultrasound Obstet Gynecol (2012) 2.65
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J (1999) 2.64
Nucleotide sequence of a complete mouse intracisternal A-particle genome: relationship to known aspects of particle assembly and function. J Virol (1987) 2.57
Localization of gene for human p53 tumour antigen to band 17p13. Nature (1986) 2.56
Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene (1999) 2.43
EBP-80, a transcription factor closely resembling the human autoantigen Ku, recognizes single- to double-strand transitions in DNA. J Biol Chem (1993) 2.34
Synthesis and transmethylation of DNA in polyoma-infected cultures. Virology (1965) 2.31
Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell (2000) 2.30
p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol (1993) 2.27
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A (1994) 2.25
A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res (1995) 2.23
Different tumor-derived p53 mutants exhibit distinct biological activities. Science (1990) 2.20
Some structural and antigenic properties of intracisternal A particles occurring in mouse tumors (complement fixation-immunodiffusion-neuroblastoma-plasma-cell tumor). Proc Natl Acad Sci U S A (1972) 2.19
Indiscriminate recombination in simian virus 40-infected monkey cells. Proc Natl Acad Sci U S A (1980) 2.18
The 5' region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. EMBO J (1985) 2.17
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12
Properties of permissive monkey cells transformed by UV-irradiated simian virus 40. J Virol (1977) 2.03
Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J Virol (1995) 2.02
MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol (1999) 2.00
The extraction of intracisternal A-particles from a mouse plasma-cell tumor. Cancer Res (1968) 1.99
Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene. Nature (1983) 1.98
A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol (1996) 1.98
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature (1996) 1.98
Oligomerization of oncoprotein p53. J Virol (1988) 1.98
A novel DNA polymerase activity found in association with intracisternal A-type particles. Proc Natl Acad Sci U S A (1972) 1.94
In vivo labeling patterns of free polyribosomes: relationship to tape theory of messenger ribonucleic acid function. J Mol Biol (1967) 1.93
Hybridization between SV40 DNA and cellular DNA's. J Mol Biol (1969) 1.92
SV40 large tumor antigen can regulate some cellular transcripts in a positive fashion. Cell (1982) 1.85
The isolation and some properties of rat liver mitochondrial deoxyribonucleic acid. Proc Natl Acad Sci U S A (1965) 1.84
Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J (1996) 1.82
Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol Cell Biol (1982) 1.82
Transcription regulation by mutant p53. Oncogene (2007) 1.78
Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes. EMBO J (1993) 1.77
Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene (1993) 1.77
Spontaneous and detergent activation of a glucuronyltransferase in vitro. Arch Biochem Biophys (1967) 1.74
Different forms of simian virus 40 large tumor antigen varying in their affinities for DNA. J Virol (1982) 1.72
RNA associated with murine intracisternal type A particles codes for the main particle protein. J Virol (1978) 1.69
Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J (2001) 1.69
Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J Virol (1989) 1.67
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene (2000) 1.67
Cellular and cell-free synthesis of simian virus 40 T-antigens in permissive and transformed cells. J Virol (1978) 1.66
Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen. Proc Natl Acad Sci U S A (1983) 1.65
Physical and functional interaction between p53 and the Werner's syndrome protein. J Biol Chem (1999) 1.64
The structural relationships between 54,000-molecular-weight cellular tumor antigens detected in viral- and nonviral-transformed cells. Virology (1981) 1.64
Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J (1994) 1.64
Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J (1999) 1.63
Quantitation of a simian virus 40 nonhomologous recombination pathway. J Virol (1983) 1.62
Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol Cell Biol (1991) 1.61
Down-regulation of beta-catenin by activated p53. Mol Cell Biol (2001) 1.60
Ketamine enhances local anesthetic and analgesic effects of bupivacaine by peripheral mechanism: a study in postoperative patients. Neurosci Lett (1996) 1.56
DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J Biol Chem (1994) 1.56
Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene (1999) 1.56